Contraindications include a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, or severe pancreatitis
By mimicking the actions of GLP-1, a naturally occurring hormone, it helps individuals maintain steady blood sugar levels , mitigating the spikes that are commonly associated with type 2 diabetes

GLP-1 Peptide Synthesis CDMO Market Report Scope Segmentation of GLP-1 Peptide Synthesis CDMO Market Global GLP-1 Peptide Synthesis CDMO Market - By Synthesis Technology Solid-Phase Peptide Synthesis (SPPS) Liquid-Phase Peptide Synthesis (LPPS) Group-Assisted Purification Peptide Synthesis (GAP-PS) Hybrid Technology Recombinant DNA Technology Global GLP-1 Peptide Synthesis CDMO Market By Service Type Analytical and Process Development Large-Scale Production Custom Peptide Synthesis Peptide Modification Purification Technology Formulation Development Regulatory Support Packaging and Labeling Pre-Formulation and Registration Batches Global GLP-1 Peptide Synthesis CDMO Market By Scale of Operation Clinical-Scale Manufacturing Commercial-Scale Manufacturing Pilot-Scale Manufacturing Global GLP-1 Peptide Synthesis CDMO Market By End-User Pharmaceutical Companies Biotechnology Companies Research Institutions Global GLP-1 Peptide Synthesis CDMO Market By Region North America- The US Canada Europe- Germany The UK France Italy Spain Rest of Europe Asia-Pacific- China Japan India South Korea Southeast Asia Rest of Asia Pacific Latin America- Brazil Mexico Rest of Latin America Middle East & Africa- GCC Countries South Africa Rest of the Middle East and Africa Research Design and Approach This study employed a multi-step, mixed-method research approach that integrates: Secondary research Primary research Data triangulation Hybrid top-down and bottom-up modelling Forecasting and scenario analysis This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market

Mounjaro doesnt have the same heart rate or dysesthesia concerns, and its longer time on the UK market means we have a clearer view of who tolerates it well
As consumer interest in prescription weight loss treatment access through telehealth platforms continues to grow heading into 2026, updated service disclosures for Hims GLP-1 Weight Lossa prescription-only offeringhave recently become publicly available